Health Economics Policy and Law

Papers
(The median citation count of Health Economics Policy and Law is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Australia's Response to COVID-19100
Response to COVID-19: was Italy (un)prepared?53
France's response to the Covid-19 pandemic: between a rock and a hard place36
Need, demand, supply in health care: working definitions, and their implications for defining access35
United States response to the COVID-19 pandemic, January–November 202028
Going hard and early: Aotearoa New Zealand's response to Covid-1923
Unmasking a health care system: the Dutch policy response to the Covid-19 crisis22
Soft law and individual responsibility: a review of the Swedish policy response to COVID-1915
The federal government and Canada's COVID-19 responses: from ‘we're ready, we're prepared’ to ‘fires are burning’15
Belgium's response to the COVID-19 pandemic12
Any lessons to learn? Pathways and impasses towards health system resilience in post-pandemic times12
Ireland's takeover of private hospitals during the COVID-19 pandemic12
Past experiences with surprise medical bills drive issue knowledge, concern and attitudes toward federal policy intervention9
An application of PCA-DEA with the double-bootstrap approach to estimate the technical efficiency of New Zealand District Health Boards9
Understanding public procurement within the health sector: a priority in a post-COVID-19 world9
Do patients benefit from legislation regulating step therapy?8
Expanding health care coverage in Canada: a dramatic shift in the debate7
We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment6
Strengthening health system governance in Germany: looking back, planning ahead6
Learning lessons from the COVID-19 pandemic6
Physician behaviour, malpractice risk and defensive medicine: an investigation of cesarean deliveries6
Internal barriers to efficiency: why disinvestments are so difficult. Identifying and addressing internal barriers to disinvestment of health technologies5
(Re)defining legitimacy in Canadian drug assessment policy? Comparing ideas over time5
Mandatory reporting legislation in Canada: improving systems for patient safety?5
Pricing strategies, executive committee power and negotiation leverage in New Zealand's containment of public spending on pharmaceuticals5
Just a question of time? Explaining non-take-up of a public health insurance program designed for undocumented immigrants living in France4
If you were a policymaker, which treatment would you disinvest? A participatory value evaluation on public preferences for active disinvestment of health care interventions in the Netherlands4
New governance of the digital health agency: a way out of the joint decision trap to implement electronic health records in Germany?3
Exorcising the positivist ghost in the priority-setting machine: NICE and the demise of the ‘social value judgement’3
Why we need to face up to the ageing population?3
Trump v. The ACA3
The normative grounds for NICE decision-making: a narrative cross-disciplinary review of empirical studies3
Health misinformation and freedom of expression: considerations for policymakers3
Public health by organizational fix?2
‘Nurses are seen as general cargo, not the smart TVs you ship carefully’: the politics of nurse staffing in England, Spain, Sweden, and the Netherlands2
Privatising, liberalising and dividing a welfare state without affecting universality? Debunking the myths surrounding the rapid rise of private health insurance in Sweden2
Can Asia provide models for tax-based European health systems? A comparative study of Singapore and Sweden2
Strengthening primary health care in China: governance and policy challenges2
Effects of public long-term care insurance on the medical service use by older people in South Korea2
Coping with COVID-19: the role of hospital care structures and capacity expansion in five countries2
Is the emergency department used as a substitute or a complement to primary care in Medicaid?2
Observations from a small country: mental health policy, services and nursing in Wales2
Accelerating integration of social needs into mainstream healthcare to achieve health equity in the COVID-19 era2
The effects of a sugar-sweetened beverage tax: moving beyond dental health outcomes and service utilisation2
Impact on the NHS and health of the UK's trade and cooperation relationship with the EU, and beyond2
Clinical negligence cases in the English NHS: uncertainty in evidence as a driver of settlement costs and societal outcomes1
Does voluntary health insurance reduce the use of and the willingness to finance public health care in Sweden?1
Structuring complexity? A systemic perspective on the implementation of a disease management programme for type II diabetes care in Denmark1
What's the ideal World Health Organization (WHO)?1
Explaining health system responses to public reporting of cardiac surgery mortality in England and the USA1
Tort reform: do details matter?1
Explaining system-level change in welfare governance: the role of policy indeterminacy and concatenations of social mechanisms1
Publicly funded health insurance schemes and demand for health services: evidence from an Indian state using a matching estimator approach1
Value-based evidence across health care sectors: a push for transparent real-world studies, data, and evidence dissemination1
Improving access to healthcare in Ireland: an implementation failure1
Fellow travellers in transformative times: a reflection on 21 years membership of the European Health Policy Group1
Health care reform and financial crisis in the Netherlands: consequences for the financial arena of health care organizations1
Early child health in Africa: do ICT and democracy matter?1
Ten years of German benefit assessment: price analysis for drugs with unproven additional benefit1
The forgotten dimension of integrated care: barriers to implementing integrated clinical care in English NHS hospitals1
Institutional boundaries and the challenges of aligning science advice and policy dynamics: the UK and Canada in the time of COVID-191
Exploring differences between public and private providers in primary care: findings from a large Swedish region1
0.030529975891113